Detalles de la búsqueda
1.
Activation of the chemokine receptor 3 pathway leads to a better response to immune checkpoint inhibitors in patients with metastatic urothelial carcinoma.
Cancer Cell Int
; 22(1): 186, 2022 May 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35562800
2.
MHC-II Signature Correlates With Anti-Tumor Immunity and Predicts anti-PD-L1 Response of Bladder Cancer.
Front Cell Dev Biol
; 10: 757137, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35223828
3.
Association Between FSIP2 Mutation and an Improved Efficacy of Immune Checkpoint Inhibitors in Patients With Skin Cutaneous Melanoma.
Front Mol Biosci
; 8: 629330, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34113648
Resultados
1 -
3
de 3
1
Próxima >
>>